Cargando…

Drug Induced Liver Injury: Perspective of the Adverse Drug Reaction Reports to the Portuguese Pharmacovigilance System from 2010 to 2019

Background: Drug induced liver injury (DILI) is an adverse drug reaction that causes liver damage in a predictable (dose-dependent) or an unpredictable (idiosyncratic) fashion. We performed an assessment of DILI in Portugal, by analyzing the reports, sent to the Portuguese Pharmacovigilance System (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nunes, David Ricardo da Conceição Marçal Alves, Breton, Michèle Claire, Monteiro, Cristina Sofia de Jesus, dos Santos, Jorge Luiz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8702164/ https://www.ncbi.nlm.nih.gov/pubmed/34946356 http://dx.doi.org/10.3390/healthcare9121630

Ejemplares similares

Adverse Drug Reactions and Potentially Inappropriate Medication in Older Patients: Analysis of the Portuguese Pharmacovigilance Database
por: Gomes, Daniel, et al.
Publicado: (2022)

Inhaled Drug Therapy-Associated Adverse Reactions in Obstructive Respiratory Diseases: A Review of a Decade of Reporting to the Portuguese Pharmacovigilance System
por: Fonseca, Willy, et al.
Publicado: (2021)

Quality of Spontaneous Reports of Adverse Drug Reactions Sent to a Regional Pharmacovigilance Unit
por: Salvador, Mário Rui, et al.
Publicado: (2022)

Status of adverse drug reaction monitoring and pharmacovigilance in selected countries
por: Yadav, Sachdev
Publicado: (2008)

Adverse drug reactions reporting culture in Pharmacovigilance Programme of India
por: Kalaiselvan, Vivekanandan, et al.
Publicado: (2014)

Adverse drug reactions monitoring: prospects and impending challenges for pharmacovigilance
por: Sahu, Ram Kumar, et al.
Publicado: (2014)

Pharmacovigilance: pharmacists’ perspective on spontaneous adverse drug reaction reporting
por: Hadi, Muhammad Abdul, et al.
Publicado: (2017)

Healthcare professionals’ awareness and knowledge of adverse drug reactions and pharmacovigilance
por: Almandil, Noor B.
Publicado: (2016)

Pharmacovigilance and spontaneous adverse drug reaction reporting: Challenges and opportunities
por: Desai, Mira
Publicado: (2022)

PDG17 Adverse Drug Reactions Associated to Hydroxychloroquine and Remdesivir in COVID-19 Patients: Analysis of Reported ADR to the Portuguese Pharmacovigilance System
por: Ivos, R., et al.
Publicado: (2021)

Safety of Non-Steroidal Anti-Inflammatory Drugs in the Elderly: An Analysis of Published Literature and Reports Sent to the Portuguese Pharmacovigilance System
por: Monteiro, Cristina, et al.
Publicado: (2022)

An adverse drug reaction clinic: Breathing fresh life into the pharmacovigilance programme
por: Brashier, Dick B. S., et al.
Publicado: (2012)

Under-reporting of adverse drug reactions: A challenge for pharmacovigilance in India
por: Tandon, Vishal R., et al.
Publicado: (2015)

Antiretroviral adverse drug reactions pharmacovigilance in Harare City, Zimbabwe, 2017
por: Mugauri, Hamufare, et al.
Publicado: (2018)

Bibliometric analysis of adverse drug reactions and pharmacovigilance research activities in Nepal
por: Shrestha, Sunil, et al.
Publicado: (2020)

Serious adverse drug reactions with hydroxychloroquine: a pharmacovigilance study in Vigibase®
por: Montastruc, Jean-Louis, et al.
Publicado: (2020)

Adverse Drug Reactions with Drugs Used in Multiple Sclerosis: An Analysis from the Italian Pharmacovigilance Database
por: Barbieri, Maria Antonietta, et al.
Publicado: (2022)

Drug_SNSMiner: standard pharmacovigilance pipeline for detection of adverse drug reaction using SNS data
por: Lee, Seunghee, et al.
Publicado: (2023)

Adverse drug reaction monitoring: support for pharmacovigilance at a tertiary care hospital in Northern Brazil
por: Lobo, Márcia Germana Alves de Araújo, et al.
Publicado: (2013)

Pharmacy students’ knowledge and perceptions about adverse drug reactions reporting and pharmacovigilance
por: Rajiah, Kingston, et al.
Publicado: (2016)

Targeted therapies and adverse drug reactions in oncology: the role of clinical pharmacist in pharmacovigilance
por: Fornasier, G., et al.
Publicado: (2018)

Adverse drug reactions reporting in Turkey and barriers: an urgent need for pharmacovigilance education
por: Khan, Zakir, et al.
Publicado: (2020)

Adverse drug reaction profile in Amravati region of India: A pharmacovigilance study
por: Bansod, Kishor A, et al.
Publicado: (2020)

Fatal Events Associated with Adverse Drug Reactions in the Korean National Pharmacovigilance Database
por: Jo, Hyeong-Geun, et al.
Publicado: (2021)

Analysis of Adverse Drug Reactions in Pediatric Patients with Epilepsy: An Intensive Pharmacovigilance Study
por: Hernández García, Ernestina, et al.
Publicado: (2023)

Adverse drug reaction profile of microtubule-damaging antineoplastic drugs: A focused pharmacovigilance study in India
por: Manohar, Hasitha Diana, et al.
Publicado: (2016)

Pharmacist’s knowledge, practice and attitudes toward pharmacovigilance and adverse drug reactions reporting process
por: Suyagh, Maysa, et al.
Publicado: (2015)

Investigation of the characteristics of medication errors and adverse drug reactions using pharmacovigilance data in China
por: Tan, Xiaofang, et al.
Publicado: (2020)

Adverse Drug Reactions of Intranasal Corticosteroids in the Netherlands: An Analysis from the Netherlands Pharmacovigilance Center
por: Rollema, Corine, et al.
Publicado: (2022)

Herb-Induced Liver Injury—A Challenging Diagnosis
por: Nunes, David Ricardo da Conceição Marçal Alves, et al.
Publicado: (2022)

Pharmacovigilance of cutaneous adverse drug reactions in associations with drugs and medical conditions: a retrospective study of hospitalized patients
por: Zheng, Lei, et al.
Publicado: (2022)

Spontaneous Reports of Serious Adverse Drug Reactions Resulting From Drug–Drug Interactions: An Analysis From the French Pharmacovigilance Database
por: Létinier, Louis, et al.
Publicado: (2021)

Headache as an Adverse Reaction to the Use of Medication in the Elderly: A Pharmacovigilance Study
por: Monteiro, Cristina, et al.
Publicado: (2021)

Incidence and risk factors of adverse drug reactions in patients with coronavirus disease 2019: A pharmacovigilance experience utilizing an ADR trigger tool
por: Alshehail, Bashayer, et al.
Publicado: (2022)

Pharmacovigilance and adverse drug reaction reporting perspectives among interns and postgraduates of a teaching hospital
por: Sharma, Raghava, et al.
Publicado: (2014)

Considering sex-specific adverse drug reactions should be a priority in pharmacovigilance and pharmacoepidemiological studies
por: Lapeyre-Mestre, Maryse
Publicado: (2019)

Safety of Anthroposophic Medicinal Products: An Analysis of Adverse Drug Reactions from German Pharmacovigilance Databases
por: Jong, Miek C., et al.
Publicado: (2021)

Signals of Adverse Drug Reactions Communicated by Pharmacovigilance Stakeholders: A Scoping Review of the Global Literature
por: Sartori, Daniele, et al.
Publicado: (2022)

Pharmacovigilance and Adverse Drug Reactions Reporting: Healthcare Providers' Experiences from Southern Highland Tanzania
por: Mwakawanga, Dorkasi L., et al.
Publicado: (2023)

Adverse Drug Reaction Reporting and Prescribing Trends of Drugs for Attention Deficit Hyperactivity Disorder in Primary Care England, 2010–2019
por: Hasan, Syed Shahzad, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_k2r14qs4k4nica3tm3ogs7d45q